These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 7921601)
1. Peripheral and central adrenoceptor modulation of the behavioural effects of clozapine in the paw test. Prinssen EP; Ellenbroek BA; Cools AR Br J Pharmacol; 1994 Jul; 112(3):769-74. PubMed ID: 7921601 [TBL] [Abstract][Full Text] [Related]
2. Combined antagonism of adrenoceptors and dopamine and 5-HT receptors underlies the atypical profile of clozapine. Prinssen EP; Ellenbroek BA; Cools AR Eur J Pharmacol; 1994 Sep; 262(1-2):167-70. PubMed ID: 7813569 [TBL] [Abstract][Full Text] [Related]
3. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system. Romero TR; Resende LC; Guzzo LS; Duarte ID Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980 [TBL] [Abstract][Full Text] [Related]
4. The paw test: a behavioural paradigm for differentiating between classical and atypical neuroleptic drugs. Ellenbroek BA; Peeters BW; Honig WM; Cools AR Psychopharmacology (Berl); 1987; 93(3):343-8. PubMed ID: 2893411 [TBL] [Abstract][Full Text] [Related]
5. The effects of haloperidol and raclopride in the paw test are influenced similarly by SCH 39166. Prinssen EP; Ellenbroek BA; Stamatovic B; Cools AR Eur J Pharmacol; 1993 Feb; 231(2):275-80. PubMed ID: 8095900 [TBL] [Abstract][Full Text] [Related]
6. The Paw test: an animal model for neuroleptic drugs which fulfils the criteria for pharmacological isomorphism. Ellenbroek B; Cools AR Life Sci; 1988; 42(12):1205-13. PubMed ID: 2894605 [TBL] [Abstract][Full Text] [Related]
7. Adrenergic receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour. Ikeda H; Moribe S; Sato M; Kotani A; Koshikawa N; Cools AR Eur J Pharmacol; 2007 Jan; 554(2-3):175-82. PubMed ID: 17113067 [TBL] [Abstract][Full Text] [Related]
8. The role of serotonin receptor subtypes in the behavioural effects of neuroleptic drugs. A paw test study in rats. Ellenbroek BA; Prinssen EP; Cools AR Eur J Neurosci; 1994 Jan; 6(1):1-8. PubMed ID: 7907518 [TBL] [Abstract][Full Text] [Related]
9. Agonist and antagonist characterization of a putative adrenoceptor with distinct pharmacological properties from the alpha- and beta-subtypes. Bond RA; Clarke DE Br J Pharmacol; 1988 Nov; 95(3):723-34. PubMed ID: 2905184 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of propranolol-sensitive beta-adrenoceptor signaling after inhibition of nitric oxide synthesis. Whalen EJ; Bates JN; Johnson AK; Lewis SJ Br J Pharmacol; 2006 Apr; 147(7):755-64. PubMed ID: 16474417 [TBL] [Abstract][Full Text] [Related]
11. Mediation of the positive chronotropic effect of CGP 12177 and cyanopindolol in the pithed rat by atypical beta-adrenoceptors, different from beta 3-adrenoceptors. Malinowska B; Schlicker E Br J Pharmacol; 1996 Mar; 117(5):943-9. PubMed ID: 8851515 [TBL] [Abstract][Full Text] [Related]
12. Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat. Kaumann AJ; Molenaar P Br J Pharmacol; 1996 Aug; 118(8):2085-98. PubMed ID: 8864547 [TBL] [Abstract][Full Text] [Related]
13. beta(2) and beta(3)-adrenoceptor inhibition of alpha(1)-adrenoceptor-stimulated Ca(2+) elevation in human cultured prostatic stromal cells. Haynes JM Eur J Pharmacol; 2007 Sep; 570(1-3):18-26. PubMed ID: 17617401 [TBL] [Abstract][Full Text] [Related]
14. Involvement of pertussis toxin-sensitive and -insensitive mechanisms in alpha-adrenoceptor modulation of noradrenaline release from rat sympathetic neurones in tissue culture. Hill CE; Powis DA; Hendry IA Br J Pharmacol; 1993 Sep; 110(1):281-8. PubMed ID: 8106104 [TBL] [Abstract][Full Text] [Related]
15. Propranolol blocks chronic risperidone treatment-induced enhancement of spatial working memory performance of rats in a delayed matching-to-place water maze task. Lim EP; Verma V; Nagarajah R; Dawe GS Psychopharmacology (Berl); 2007 Apr; 191(2):297-310. PubMed ID: 17225165 [TBL] [Abstract][Full Text] [Related]
16. In vivo effects of noradrenaline and noradrenergic receptor agonists and antagonists on rat cerebellar cyclic GMP levels. Haidamous M; Kouyoumdjian JC; Briley PA; Gonnard P Eur J Pharmacol; 1980 May; 63(4):287-94. PubMed ID: 6104602 [TBL] [Abstract][Full Text] [Related]
17. Atypical beta-adrenoceptors, different from beta 3-adrenoceptors and probably from the low-affinity state of beta 1-adrenoceptors, relax the rat isolated mesenteric artery. Kozłowska H; Szymska U; Schlicker E; Malinowska B Br J Pharmacol; 2003 Sep; 140(1):3-12. PubMed ID: 12967929 [TBL] [Abstract][Full Text] [Related]
18. Effect of adrenoceptor agonists on striated muscle strips of the canine oesophagus. Tokuhara T; Meulemans AL; De Ridder WJ; Higashino M; Kinoshita H; Schuurkes JA Br J Pharmacol; 1993 Sep; 110(1):297-302. PubMed ID: 8106105 [TBL] [Abstract][Full Text] [Related]
19. Effects of adrenoceptor agents on apomorphine-induced licking behavior in rats. Zarrindast MR; Fazli-Tabaei S; Semnanian S; Fathollah Y; Yahyavi SH Pharmacol Biochem Behav; 2000 Feb; 65(2):275-9. PubMed ID: 10672980 [TBL] [Abstract][Full Text] [Related]
20. The effect of beta-adrenoceptor antagonists on the alpha-adrenoceptor blockade produced by phenoxybenzamine. Sankaranarayanan A; Sharma PL Arch Int Pharmacodyn Ther; 1977 May; 227(1):11-22. PubMed ID: 20067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]